Please login to the form below

Not currently logged in
Email:
Password:

Kala Pharmaceuticals

This page shows the latest Kala Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Sanofi’s Guillaume Pfefer joins Kala as CEO

Former Sanofi executive Guillaume Pfefer has been appointed president and CEO of Kala Pharmaceuticals. ... He said: “ Kala has developed an innovative approach to transform treatments for a range of serious diseases.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Vedanta Biosciences appoints two new heads Vedanta Biosciences appoints two new heads

    Schopf formerly served as the senior director of preclinical development at Kala Pharmaceuticals and has over 20 years of industry experience.

  • ARC names chairman and member of the board ARC names chairman and member of the board

    Iwicki is executive chairman of the board of directors of Kala Pharmaceuticals and sits on the boards of Nimbus Therapeutics and Taris Biomedical.

  • Kala names Howard Rosen as chairman Kala names Howard Rosen as chairman

    Kala Pharmaceuticals has appointed life sciences industry veteran Howard Rosen as chairman of the board of directors. ... Kala's president and CEO Guillaume Pfefer commented on this rich experience when welcoming Rosen. “

  • Allergan veteran joins Kala as head of business development Allergan veteran joins Kala as head of business development

    Charles McDermott, who has spent the last eight years at Allergan, has joined serious disease specialist Kala Pharmaceuticals as executive VP, business development. ... He also has research experience, serving as a research scientist at Agouron

  • Kala Pharma appoints Fovea founder Bernard Gilly to board Kala Pharma appoints Fovea founder Bernard Gilly to board

    Kala Pharma appoints Fovea founder Bernard Gilly to board. He previously formed the company that became Sanofi’ s ophthalmology business. ... Dr Bernard Gilly, founder and CEO of Sanofi-owned Fovea, has joined the board of Kala Pharmaceuticals.

More from appointments
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics